Tian Tian, Xiao Hongrui, Guo Xinyi, Chen Yuxin, Qiu Zhiqiang, Zhang Ting, Chen Meiyu, Qi Weiwei, Cai Peige, Cheng Meng, Zhou Xiaoming
School of Life sciences, South China Normal University, Guangzhou, China.
Department of Clinical Laboratory, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Nat Commun. 2025 Jul 21;16(1):6694. doi: 10.1038/s41467-025-62082-5.
Developing a one-pot assay is a critical strategy for enhancing the applicability of CRISPR-based molecular diagnostics; however, it is hindered by CRISPR cleavage interfering with nucleic acid amplification templates. Photo-regulation strategies provide an ideal solution to suppress undesired CRISPR cleavage while maintaining detection efficiency. However, existing photo-controlled CRISPR diagnostic methods face limitations in universality, cost, and detection efficiency. In this study, we systematically examine the impact of mutations in the repeat recognition sequence (RRS), a four-nucleotide segment within the Cas12a crRNA direct repeat (DR) region, on cleavage activity. We observe that mutations at positions 3 or 4 nearly abolished crRNA activity. Based on this discovery, we introduce 6-nitropiperonyloxymethyl (NPOM) photo-caging modifications at positions 3 and 4. Photo-caging at position 4 demonstrates the most effective suppression of enzymatic activity and optimal light-mediated activation. We leverage this finding to develop a photo-controlled CRISPR diagnostic method, enabling a universally adaptable one-pot detection strategy. Furthermore, by incorporating a crRNA splinting strategy, this pre-preparable reagent can be adapted for the detection of virtually any target gene.
开发一种一锅法检测是提高基于CRISPR的分子诊断适用性的关键策略;然而,它受到CRISPR切割干扰核酸扩增模板的阻碍。光调控策略为抑制不必要的CRISPR切割同时保持检测效率提供了理想的解决方案。然而,现有的光控CRISPR诊断方法在通用性、成本和检测效率方面存在局限性。在本研究中,我们系统地研究了重复识别序列(RRS)中的突变对切割活性的影响,RRS是Cas12a crRNA直接重复(DR)区域内的一个四核苷酸片段。我们观察到第3或第4位的突变几乎消除了crRNA活性。基于这一发现,我们在第3和第4位引入了6-硝基胡椒基氧甲基(NPOM)光笼修饰。第4位的光笼修饰显示出对酶活性的最有效抑制和最佳的光介导激活。我们利用这一发现开发了一种光控CRISPR诊断方法,实现了一种普遍适用的一锅法检测策略。此外,通过纳入crRNA夹板策略,这种预制备的试剂可适用于几乎任何靶基因的检测。